Recurrent somatic mutations in NK-cell enteropathy.
作者信息
Xiao Wenbin, Gupta Gaurav K, Yao Jinjuan, Jang Yoon J, Xi Liqiang, Baik Jeeyeon, Sigler Allison, Kumar Anita, Moskowitz Alison J, Arcila Maria E, Raffeld Mark, Pittaluga Stefania, Dogan Ahmet, Jaffe Elaine S
机构信息
Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY.
Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD; and.
出版信息
Blood. 2019 Sep 19;134(12):986-991. doi: 10.1182/blood.2019001443. Epub 2019 Aug 5.
Abstract
摘要
相似文献
1
Recurrent somatic mutations in NK-cell enteropathy.自然杀伤细胞肠病中的复发性体细胞突变。
Blood. 2019 Sep 19;134(12):986-991. doi: 10.1182/blood.2019001443. Epub 2019 Aug 5.
2
Clinical and genetic profile of Chinese patients with indolent natural killer-cell lymphoproliferative disorder of the gastrointestinal tract.中国惰性 NK 细胞胃肠间质性淋巴组织增生症患者的临床和遗传学特征。
Neoplasia. 2024 Nov;57:101048. doi: 10.1016/j.neo.2024.101048. Epub 2024 Sep 13.
3
NK-cell enteropathy, a potential diagnostic pitfall of intestinal lymphoproliferative disease.自然杀伤细胞肠病，肠道淋巴增殖性疾病的一个潜在诊断陷阱。
Pathology. 2019 Apr;51(3):338-340. doi: 10.1016/j.pathol.2018.09.064. Epub 2019 Feb 26.
4
NK cell enteropathy: a case report with 10 years of indolent clinical behaviour.自然杀伤细胞肠病：10 年惰性临床行为的病例报告。
Histopathology. 2018 Aug;73(2):345-350. doi: 10.1111/his.13502. Epub 2018 May 21.
5
A high definition picture of somatic mutations in chronic lymphoproliferative disorder of natural killer cells.高清晰度图片展示自然杀伤细胞慢性淋巴增生性疾病中的体细胞突变。
Blood Cancer J. 2020 Apr 22;10(4):42. doi: 10.1038/s41408-020-0309-2.
6
T- and NK-cell lymphoproliferative disorders of the gastrointestinal tract: review and update.T 细胞和 NK 细胞胃肠道淋巴组织增生性疾病：综述与更新。
Pathology. 2020 Jan;52(1):128-141. doi: 10.1016/j.pathol.2019.10.001. Epub 2019 Nov 11.
7
NK-Cell Enteropathy and Similar Indolent Lymphoproliferative Disorders: A Case Series With Literature Review.自然杀伤细胞肠病及类似惰性淋巴增生性疾病：病例系列及文献复习
Am J Clin Pathol. 2019 Jan 1;151(1):75-85. doi: 10.1093/ajcp/aqy108.
8
Novel JAK3-Activating Mutations in Extranodal NK/T-Cell Lymphoma, Nasal Type.结外 NK/T 细胞淋巴瘤，鼻型中的新型 JAK3 激活突变。
Am J Pathol. 2017 May;187(5):980-986. doi: 10.1016/j.ajpath.2017.01.004. Epub 2017 Mar 9.
9
Janus kinase 3-activating mutations identified in natural killer/T-cell lymphoma.自然杀伤/T 细胞淋巴瘤中鉴定出的 Janus 激酶 3 激活突变。
Cancer Discov. 2012 Jul;2(7):591-7. doi: 10.1158/2159-8290.CD-12-0028. Epub 2012 Jun 15.
10
STAT3 mutations in natural killer cells are associated with cytopenia in patients with chronic lymphoproliferative disorder of natural killer cells.自然杀伤细胞中的 STAT3 突变与慢性 NK 细胞淋巴增生性疾病患者的血细胞减少症有关。
Int J Hematol. 2019 May;109(5):563-571. doi: 10.1007/s12185-019-02625-x. Epub 2019 Mar 11.
引用本文的文献
1
Clinicopathologic features and molecular profiling of indolent NK-cell lymphoproliferative disorder of the gastrointestinal tract.胃肠道惰性自然杀伤细胞淋巴增殖性疾病的临床病理特征及分子剖析
Gastroenterol Rep (Oxf). 2025 Jul 18;13:goaf047. doi: 10.1093/gastro/goaf047. eCollection 2025.
2
Exploring the boundaries between neoplastic and reactive lymphoproliferations: lymphoid neoplasms with indolent behavior and clonal lymphoproliferations-a report of the 2024 EA4HP/SH lymphoma workshop.探索肿瘤性与反应性淋巴细胞增殖之间的界限：具有惰性行为的淋巴肿瘤和克隆性淋巴细胞增殖——2024年EA4HP/SH淋巴瘤研讨会报告
Virchows Arch. 2025 Jul 5. doi: 10.1007/s00428-025-04168-5.
3
Indolent NK-cell lymphoproliferative disorder of the gastrointestinal tract complicated by protein-losing enteropathy: A case report.胃肠道惰性自然杀伤细胞淋巴增殖性疾病合并蛋白丢失性肠病：一例报告
World J Radiol. 2025 May 28;17(5):107141. doi: 10.4329/wjr.v17.i5.107141.
4
What is new in the 5th edition of the World Health Organization classification of mature B and T/NK cell tumors and stromal neoplasms?第五版世界卫生组织成熟 B 和 T/NK 细胞肿瘤和间质肿瘤分类有哪些新内容？
J Hematop. 2024 Jun;17(2):71-89. doi: 10.1007/s12308-024-00585-8. Epub 2024 Apr 29.
5
Janus Kinase 3 (JAK3): A Critical Conserved Node in Immunity Disrupted in Immune Cell Cancer and Immunodeficiency.Janus激酶3（JAK3）：免疫中的关键保守节点，在免疫细胞癌症和免疫缺陷中被破坏。
Int J Mol Sci. 2024 Mar 4;25(5):2977. doi: 10.3390/ijms25052977.
6
What is new in the classification of peripheral T cell lymphomas?外周 T 细胞淋巴瘤的分类有哪些新进展？
Pathologie (Heidelb). 2023 Dec;44(Suppl 3):128-135. doi: 10.1007/s00292-023-01260-y. Epub 2023 Dec 4.
7
Biology and genetics of extranodal mature T-cell and NKcell lymphomas and lymphoproliferative disorders.结外成熟 T 细胞和 NK 细胞淋巴瘤和淋巴增殖性疾病的生物学和遗传学。
Haematologica. 2023 Dec 1;108(12):3261-3277. doi: 10.3324/haematol.2023.282718.
8
Few and far between: clinical management of rare extranodal subtypes of mature T-cell and NK-cell lymphomas.寥寥无几：罕见结外成熟 T 细胞和 NK 细胞淋巴瘤的临床处理方法。
Haematologica. 2023 Dec 1;108(12):3244-3260. doi: 10.3324/haematol.2023.282717.
9
Updates in the Classification of T-cell Lymphomas and Lymphoproliferative Disorders.T 细胞淋巴瘤和淋巴组织增生性疾病分类的更新。
Curr Hematol Malig Rep. 2023 Dec;18(6):252-263. doi: 10.1007/s11899-023-00712-9. Epub 2023 Oct 23.
10
A Comparison of the Fifth World Health Organization and the International Consensus Classifications of Mature T-Cell Lymphomas.第五版世界卫生组织与国际成熟 T 细胞淋巴瘤共识分类的比较。
Int J Mol Sci. 2023 Sep 16;24(18):14170. doi: 10.3390/ijms241814170.
本文引用的文献
1
Recurrent fusions in indolent T-cell lymphoproliferative disorder of the gastrointestinal tract.胃肠道惰性T细胞淋巴增殖性疾病中的复发性融合
Blood. 2018 May 17;131(20):2262-2266. doi: 10.1182/blood-2018-01-830968. Epub 2018 Mar 28.
2
Mutations in the JAK/STAT and RAS signaling pathways are common in intestinal T-cell lymphomas.JAK/STAT和RAS信号通路中的突变在肠道T细胞淋巴瘤中很常见。
Leukemia. 2016 Nov;30(11):2245-2247. doi: 10.1038/leu.2016.178. Epub 2016 Jun 22.
3
Activating mutations in genes related to TCR signaling in angioimmunoblastic and other follicular helper T-cell-derived lymphomas.在血管免疫母细胞性和其他滤泡辅助 T 细胞来源的淋巴瘤中，与 TCR 信号相关的基因中的激活突变。
Blood. 2016 Sep 15;128(11):1490-502. doi: 10.1182/blood-2016-02-698977. Epub 2016 Jul 1.
4
Integrated mate-pair and RNA sequencing identifies novel, targetable gene fusions in peripheral T-cell lymphoma.整合配对末端测序和RNA测序鉴定外周T细胞淋巴瘤中的新型可靶向基因融合。
Blood. 2016 Sep 1;128(9):1234-45. doi: 10.1182/blood-2016-03-707141. Epub 2016 Jun 13.
5
Integrated genomic DNA/RNA profiling of hematologic malignancies in the clinical setting.临床环境中血液系统恶性肿瘤的基因组DNA/RNA综合分析
Blood. 2016 Jun 16;127(24):3004-14. doi: 10.1182/blood-2015-08-664649. Epub 2016 Mar 10.
6
JAK-STAT and G-protein-coupled receptor signaling pathways are frequently altered in epitheliotropic intestinal T-cell lymphoma.JAK-STAT和G蛋白偶联受体信号通路在上皮型肠道T细胞淋巴瘤中经常发生改变。
Leukemia. 2016 Jun;30(6):1311-9. doi: 10.1038/leu.2016.13. Epub 2016 Feb 8.
7
Activating mutations of STAT5B and STAT3 in lymphomas derived from γδ-T or NK cells.源自γδ-T细胞或NK细胞的淋巴瘤中STAT5B和STAT3的激活突变。
Nat Commun. 2015 Jan 14;6:6025. doi: 10.1038/ncomms7025.
8
Targeted mutational profiling of peripheral T-cell lymphoma not otherwise specified highlights new mechanisms in a heterogeneous pathogenesis.外周T细胞淋巴瘤（未另行特别说明）的靶向突变谱分析突显了异质性发病机制中的新机制。
Leukemia. 2015 Jan;29(1):237-41. doi: 10.1038/leu.2014.261. Epub 2014 Sep 3.
9
Frequent STAT5B mutations in γδ hepatosplenic T-cell lymphomas.γδ肝脾T细胞淋巴瘤中频繁出现的STAT5B突变。
Leukemia. 2014 Nov;28(11):2244-8. doi: 10.1038/leu.2014.200. Epub 2014 Jun 20.
10
Integrated genomic sequencing reveals mutational landscape of T-cell prolymphocytic leukemia.综合基因组测序揭示T细胞原淋巴细胞白血病的突变图谱。
Blood. 2014 Aug 28;124(9):1460-72. doi: 10.1182/blood-2014-03-559542. Epub 2014 May 13.
Zotero 插件